IP Library Granted Patent US 7,517,672
Granted Patent B2
US 7,517,672 · App. 11/649,452 · Granted Apr 14, 2009

Nucleic acids encoding mammalian T-type calcium channels

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,517,672
App. No.
11/649,452
Granted
Apr 14, 2009
Kind
B2
Abstract

Sequences and partial sequences for three types of mammalian (human and rat sequences identified) T-type calcium channel subunits which we have labeled as the α 1G , α 1H and α 1I subunits are provided. Knowledge of the sequence of these calcium channel permits the localization and recovery of the complete sequence from human cells, and the development of cell lines which express the novel calcium channels of the invention. These cells may be used for identifying compounds capable of acting as agonists or antagonists to the calcium channels.

Claims (10)

1. An isolated recombinant DNA molecule which comprises an expression cassette wherein said expression cassette comprises a nucleotide sequence encoding a T-type calcium channel α 1H subunit, said encoding sequence operably linked to control sequences to effect its expression; wherein said α 1H subunit has the amino acid sequence of SEQ ID NO: 26.

2. Recombinant host cells modified to contain the DNA molecule of claim 1 .

3. The cells of claim 2 which are mammalian cells.

4. A method to effect production of a recombinant functional calcium channel which method comprises culturing the cells of claim 2 under conditions wherein said functional calcium channels are produced.

5. A method to effect production of a recombinant functional calcium channel which method comprises culturing the cells of claim 3 under conditions wherein said functional calcium channels are produced.

6. An isolated nucleic acid molecule which comprises a nucleotide sequence encoding a T-type calcium channel α 1H subunit or its full-length complement, wherein said α 1H subunit has the amino acid sequence of SEQ ID NO: 26.

7. Recombinant host cells modified to contain the DNA molecule of claim 6 .

8. The cells of claim 7 which are mammalian cells.

9. A method to effect production of a recombinant functional calcium channel which method comprises culturing the cells of claim 7 under conditions wherein said functional calcium channels are produced.

10. A method to effect production of a recombinant functional calcium channel which method comprises culturing the cells of claim 8 under conditions wherein said functional calcium channels are produced.

Assignments (3)
CHANGE OF NAME Recorded Sep 15, 2010
From: NEUROMED PHARMACEUTICALS LTD.
To: ZALICUS PHARMACEUTICALS LTD.
Reel/Frame 024990/0430 →
CHANGE OF NAME Recorded Feb 23, 2009
From: NEUROMED TECHNOLOGIES INC.
To: NEUROMED PHARMACEUTICALS LTD.
Reel/Frame 022298/0092 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 9, 2007
From: SNUTCH, TERRANCE P.; BAILLIE, DAVID L.
To: NEUROMED TECHNOLOGIES, INC.
Reel/Frame 019270/0650 →